Drugs / Tiazac XC
last change Mar 2009 re-read 2 minutes ago

Tiazac XC

Developed for
diabetic kidney disease · hypertensive disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00713011 Comparator Nov 2008 → Mar 2009 diabetic kidney disease, hypertensive disorder Bayer Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tiazac XC ClinicalTrials.gov intervention name — accepted as the source's own label NCT00713011